MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 5.72
-0.06 (-1.04%)
Apr 2, 2026, 5:35 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €107.63 million as of April 2, 2026. Its market cap has increased by 31.85% in one year.
Market Cap
107.63M
Enterprise Value
107.00M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.72
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 107.63M, a decrease of -18.91%. That is a compound annual growth rate of -4.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 107.63M | 38.94% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sensorion | 218.76M |
| Cellectis | 218.50M |
| Transgene | 209.75M |
| ABIONYX Pharma | 129.82M |
| Innate Pharma | 105.35M |
| Adocia | 95.32M |
| OSE Immunotherapeutics | 73.36M |
| Valerio Therapeutics Société anonyme | 57.68M |